Komrokji, R., al Ali, N., Chan, O., Sweet, K., Kuykendall, A., Lancet, J., Padron, E. and Sallman, D. A. (2023) “<i>IDH</i&gt; mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy”, Haematologica. Pavia, Italy, 108(4), pp. 1168-1172. doi: 10.3324/haematol.2022.281607.